Related references
Note: Only part of the references are listed.MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia
Ramiro Garzon et al.
BLOOD (2008)
The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal
Jerry L. Spivak et al.
BLOOD (2008)
Haploinsufficiency of RPS14 in 5q-syndrome is associated with deregulation of ribosomal- and translation-related genes
Andrea Pellagatti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2
Catherine Helias et al.
CANCER GENETICS AND CYTOGENETICS (2008)
Cytogenetic studies at diagnosis in polycythemia vera:: clinical and JAK2V617F allele burden correlates
Naseema Gangat et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
A case of Philadelphia-chromosome positive chronic idiopathic myelofibrosis
Feng Chen et al.
LEUKEMIA RESEARCH (2008)
Disappearance of JAK2 V617F mutation in a rapid leukemic transformed essential thrombocythemia patient
Hui-Hua Hsiao et al.
LEUKEMIA RESEARCH (2008)
Peripheral blood cytogenetic studies in myelofibrosis: Overall yield and comparison with bone marrow cytogenetic studies
Kebede Hussein et al.
LEUKEMIA RESEARCH (2008)
Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
A. Tefferi et al.
LEUKEMIA (2008)
Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms
Vesna Naifeld et al.
EXPERIMENTAL HEMATOLOGY (2007)
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelotibrosis: recommendations from an ad hoc international expert panel
Ayalew Tefferi et al.
BLOOD (2007)
Lenalidomide therapy in del(5)(q31)-associated myelofibrosis:: cytogenetic and JAK2V617F molecular remissions
A. Tefferi et al.
LEUKEMIA (2007)
Leukemic blasts in transfon-ned JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation
Alexandre Theocharides et al.
BLOOD (2007)
Cytogenetics of agnogenic myeloid metaplasia: a study of 61 patients
Vesna Djordjevic et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cells
Dominique Verhelle et al.
CANCER RESEARCH (2007)
A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis
Thomas Stauffer Larsen et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Molecular profiling of CD34(+) cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1)
Paola Guglielmelli et al.
STEM CELLS (2007)
Chronic idiopathic myelofibrosis expressing a novel type of TEL-PDGFRB chimaera responded to imatinib mesylate therapy
K. Tokita et al.
LEUKEMIA (2007)
Oncogenic mechanisms in myeloproliferative disorders
F. Delhommeau et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Mutation of JAK2 in the myeloproliferative disorders:: timing, clonality studies, cytogenetic associations, and role in leukemic transformation
Peter J. Campbell et al.
BLOOD (2006)
Survival benefit with imatinib mesylate versus interferon-α-based regimens in newly diagnosed chronic-phase chronic myelogenous leukemia
Hagop M. Kantarjian et al.
BLOOD (2006)
Lenalidomide therapy in myelofibrosis with myeloid metaplasia
Ayalew Tefferi et al.
BLOOD (2006)
Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders
Robert Kralovics et al.
BLOOD (2006)
Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis
D Dingli et al.
CANCER (2006)
Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined
Michelle A. Elliot
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2006)
Pathogenesis of myelofibrosis with myeloid metaplasia
A Tefferi
JOURNAL OF CLINICAL ONCOLOGY (2005)
De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia
HH Hsiao et al.
LEUKEMIA RESEARCH (2005)
Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia
A Tefferi et al.
CANCER (2005)
Leukemic recombinations involving heterochromatin in myeloproliferative disorders with t(1;9)
C Sambani et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Philadelphia-chromosome positive thrombocythemia in a child
P Mishra et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders
U Bacher et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia
D Dingli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Identification of an acquired JAK2 mutation in Polycythemia vera
RX Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Chromosome 7 deletions are associated with unfavorable prognosis in myelofibrosis with myeloid metaplasia
K Strasser-Weippl et al.
BLOOD (2005)
Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays
LC Jones et al.
STEM CELLS (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information
U Bacher et al.
ANNALS OF HEMATOLOGY (2005)
Gains on 9p are common genomic aberrations in idiopathic myelofibrosis: a comparative genomic hybridization study
O Al-Assar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
LP Lim et al.
NATURE (2005)
Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases
RA Mesa et al.
BLOOD (2005)
Every case of essential thrombocythemia should be tested for the Philadelphia chromosome
L Rice et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
MicroRNAs modulate hematopoietic lineage differentiation
CZ Chen et al.
SCIENCE (2004)
Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia
JJ Michiels et al.
ANNALS OF HEMATOLOGY (2004)
Characterization of the imprinted polycomb gene L3MBTL, a candidate 20q tumour suppressor gene, in patients with myeloid malignancies
AJ Bench et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Is fluorescence in situ hybridization a useful method in diagnosis of polycythemia vera patients?
L Zamora et al.
CANCER GENETICS AND CYTOGENETICS (2004)
RARβ2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia
LC Jones et al.
ONCOGENE (2004)
Imprinting of the human L3MBTL gene, a polycomb family member located in a region of chromosome 20 deleted in human myeloid malignancies
J Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Allogeneic hematopoietic stem cell transplantation for myelofibrosis
HJ Deeg et al.
BLOOD (2003)
Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease
R Kralovics et al.
BLOOD (2003)
The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6)
P Boccuni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Evidence of clonality in chronic neutrophilic leukaemia
J Böhm et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
J Cools et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia
TL Reeder et al.
BLOOD (2003)
Karyotypic abnormalities in myelofibrosis following polycythemia vera
J Andrieux et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Exploring polycythaemia vera with fluorescence in situ hybridization:: additional cryptic 9p is the most frequent abnormality detected
V Najfeld et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors
S Giraudier et al.
BLOOD (2002)
Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea
P Bernasconi et al.
LEUKEMIA (2002)
Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia
J Andrieux et al.
CANCER GENETICS AND CYTOGENETICS (2002)
A novel t(16;20)(q22;p13) in polycythemia vera
M Daibata et al.
CANCER GENETICS AND CYTOGENETICS (2002)
Neutrophilic-chronic myeloid leukemia - Low levels of p230 BCR/ABL mRNA and undetectable p230 BCR/ABL protein may predict an indolent course
S Verstovsek et al.
CANCER (2002)
Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera
R Kralovics et al.
EXPERIMENTAL HEMATOLOGY (2002)
Chronic neutrophilic leukaemia: A distinct clinical entity?
JT Reilly
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Cytogenetic and molecular genetic aspects of essential thrombocythemia
DP Steensma et al.
ACTA HAEMATOLOGICA (2002)
An overview of translocation-related oncogenesis in the chronic myeloid leukaemias
BJ Bain
ACTA HAEMATOLOGICA (2002)
Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia
A Tefferi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell lines
D MacGrogan et al.
ONCOGENE (2001)
Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia
A Tefferi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Myelofibrosis with myeloid metaplasia in adult individuals 30 years old or younger:: presenting features, evolution and survival
F Cervantes et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2001)
Fluorescence in situ hybridization analysis of 25 cases of idiopathic myelofibrosis and two cases of secondary myelofibrosis:: monoallelic loss of RB1, D13S319 and D13S25 loci associated with cytogenetic deletion and translocation involving 13q14
EJ Sinclair et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
No increased frequency of trisomies 8 and 9 by fluorescence in situ hybridization in untreated patients with essential thrombocythemia
B Swolin et al.
CANCER GENETICS AND CYTOGENETICS (2001)
New reciprocal translocation t(6;10) (q27;q11) associated with idiopathic myelofibrosis and eosinophilia
MC Cox et al.
LEUKEMIA RESEARCH (2001)
Partial tetrasomy of 9p: A rare chromosomal abnormality in polycythaemia vera
AA van de Loosdrecht et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map
PW Wang et al.
GENOMICS (2000)
Long-term survival of infants with idiopathic myelofibrosis
RA Altura et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
The incidences of trisomy 8, trisomy 9 and D20S108 deletion in polycythaemia vera: an analysis of blood granulocytes using interphase fluorescence in situ hybridization
NB Westwood et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
